Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Trially AI
United States
- Kansas City, MO
- 17/09/2025
- Seed
- $4,700,000
Trially is the first AI-native clinical trial enrollment platform that matches, engages and enrolls patients at breakthrough speed and ~95% accuracy.
Loved by customers, Trially LLM agents fill trials faster—with 2-6x increase in enrollment rate, 73% fewer screen fails, and 91% less prescreening time.
Trially’s site-based software rapidly prescreens patients from any clinical data source, fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001.
Designed to meet the needs of Physicians, Sites, Sponsors and CROs, Trially AI empowers you to achieve outstanding results in clinical research.
- Industry Software Development
- Website https://www.trially.ai/
- LinkedIn https://www.linkedin.com/company/trially/
Related People
Kyle McAllisterFounder
United States -
Kansas City Metropolitan Area
Building at the intersection of the traditional provider/EHR world and clinical trials. Follow along on the journey as we create Trially.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)